PCN68 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND
Abstract
Authors
J Walczak E Gebus K Lasota A Semeniuk D Pawlik I Malczak J Lis M Glasek G Nogas